It’s becoming more and more common for Sponsors and CROs to establish shortlists or preferred providers, even for Clinical Phase 1 Units. When this happens, the site selection and site [...]
WCCT’s General Capabilities in Early Phase Clinical Trials As an early phase CRO specializing in Phase 1 and 2 clinical trials, WCCT Global has a range of capabilities in the pharmaceutical and [...]
Current Landscape of Cannabis Clinical Research As it stands, cannabis is classified as a Schedule 1 drug by the Drug Enforcement Agency (DEA). According to the DEA, a drug is classified as [...]
At some point or another, every Phase 1 clinical trial unit has or will receive a 483 from the FDA. Before we delve into what this means for a site, we’ll provide a bit of background. When are [...]
Are Staff Properly Optimized at Your Clinical Phase 1 Units? When it comes time to selecting clinical phase 1 units for a large study, there are a number of items, both basic and advanced, to [...]
